Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
1.
Nat Prod Rep ; 31(1): 15-34, 2014 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-24270605

RESUMO

Covering: 1985 to 2001.This paper describes a fifteen year journey from concept to clinical discovery and development of the first in class caspofungin acetate (CANCIDAS®) a parenteral antifungal agent. Caspofungin is a semisynthetic derivative of pneumocandin B0, a naturally occurring, lipophilic cyclic peptide isolated from the fungus, Glarea lozoyensis. While the echinocandins had been previously studied for antifungal activity by several organizations, the class was dropped for a variety of reasons. Merck subsequently initiated a research program leading to the discovery and development of caspofungin. The multitude of challenges that ensued during the discovery and development process and which were successfully resolved by multi-disciplinary teams constitute the content of this article. The article consists of five sections that describe the discovery and development of caspofungin in chronological order: (i) discovery of the natural product pneumocandin B0 from fungal fermentations, (ii) fermentation development to improve the titer of pneumocandin B0 to make it commercially viable, (iii) semisynthetic modification by medicinal chemistry to successfully improve the properties of pneumocandin B0 leading to the discovery of caspofungin, (iv) development of commercial semisynthesis and purification and formulation development to improve stability and (v) clinical development and approval of CANCIDAS® as an antifungal drug which subsequently saved thousands of lives.


Assuntos
Antifúngicos/farmacologia , Ascomicetos/química , Equinocandinas/farmacologia , Peptídeos Cíclicos/farmacologia , Antifúngicos/química , Antifúngicos/isolamento & purificação , Caspofungina , Descoberta de Drogas , Equinocandinas/química , Equinocandinas/isolamento & purificação , Humanos , Lipopeptídeos , Estrutura Molecular , Peptídeos Cíclicos/química , Peptídeos Cíclicos/isolamento & purificação
2.
J Nat Prod ; 77(6): 1280-6, 2014 Jun 27.
Artigo em Inglês | MEDLINE | ID: mdl-24933689

RESUMO

The Candida albicans fitness test is a whole cell screening platform that utilizes a mixed-pool of C. albicans mutants, each of which carries a heterozygous deletion of a particular gene. In the presence of an antifungal inhibitor, a subset of these mutants exhibits a growth phenotype of hypersensitivity or hyposensitivity. Collectively these mutants reflect aspects of the mechanism of action of the compound in question. In the course of screening natural products a culture of Streptomyces sp. MS-1-4 was discovered to produce a compound, dretamycin, which yielded a fitness profile exhibiting significant hypersensitivity of the DRE2 heterozygote and hyposensitivity of the DIP5 heterozygote. Herein we report the production, isolation, and structure elucidation of dretamycin.


Assuntos
Antifúngicos/isolamento & purificação , Produtos Biológicos/isolamento & purificação , Proteínas Fúngicas/metabolismo , Proteínas Ferro-Enxofre/metabolismo , Pirróis/isolamento & purificação , Streptomyces/química , Antifúngicos/química , Antifúngicos/farmacologia , Produtos Biológicos/química , Produtos Biológicos/farmacologia , Candida albicans/efeitos dos fármacos , Proteínas Fúngicas/genética , Proteínas Ferro-Enxofre/genética , Testes de Sensibilidade Microbiana , Estrutura Molecular , Pirróis/química , Pirróis/farmacologia
3.
Antonie Van Leeuwenhoek ; 102(2): 361-74, 2012 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-22562433

RESUMO

Despite the availability of many culture-based antibiotic screening methods, the lack of sensitive automated methods to identify functional molecules directly from microbial cells still limits the search for new biologically active compounds. The effectiveness of antibiotic detection is influenced by the solubility of the assayed compounds, indicator strain sensitivity, culture media and assay configuration. We describe a qualitative high throughput screening system for detecting cell-perturbing molecules from bacterial colonies employing two opposed agar layers sequentially formed in prototype Society for Biomolecular Screening (SBS) plates, named Janus plates. Direct assay of microbial colonies against target organisms in opposed agar layers overcomes some of the limitations of agar overlay methods. The system enables the rapid detection of extracellular cell-perturbing molecules, e.g., antibiotics, excreted directly from environmental isolates. The source bacterial colonies remain separate from the target organism. The growth layer is prepared and grown independently, so environmental strains can be grown for longer intervals, at temperatures and in media that favor their growth and metabolite expression, while the assay layer with pathogens, usually requiring nutrient-rich medium and elevated temperatures, are added later. Colonies to be tested can be precisely arrayed on the first agar surface, thus avoiding dispersion and disturbance of potential antibiotic-producing colonies by overlaying agar with the target strain. The rectangular SBS configuration facilitates factorial replication of dense microbial colony arrays for testing with multiple assays and assay conditions employing robotic colony pickers and pin tools. Opposed agar layers only slightly reduced the effectiveness for detecting growth inhibition from pure antibiotics compared to single-layer agar diffusion assays. The Janus plate enabled an automation-assisted workflow where a lone operator can effectively identify and accumulate bioactive soil bacterial strains within a few weeks. We also envisage the method's utility for functional prescreening colonies of clones from genomic and metagenomic libraries or improved strains originating from mutagenized cells.


Assuntos
Antibacterianos/metabolismo , Bactérias/metabolismo , Contagem de Colônia Microbiana/métodos , Avaliação Pré-Clínica de Medicamentos/métodos , Ensaios de Triagem em Larga Escala/métodos , Bactérias/crescimento & desenvolvimento , Contagem de Colônia Microbiana/instrumentação , Avaliação Pré-Clínica de Medicamentos/instrumentação , Ensaios de Triagem em Larga Escala/instrumentação
4.
J Nat Prod ; 72(5): 841-7, 2009 May 22.
Artigo em Inglês | MEDLINE | ID: mdl-19334707

RESUMO

Thiazolyl peptides are a class of highly rigid trimacrocyclic compounds consisting of varying but large numbers of thiazole rings. The need for new antibacterial agents to treat infections caused by resistant bacteria prompted a reinvestigation of this class, leading to the previous isolation of thiazolyl peptides, namely, thiazomycin (5) and thiazomycin A (6), congeners of nocathiacins (1-4). Continued chemical screening led to the isolation of six new thiazolyl peptide congeners (8-13), of which three had truncated structures lacking an indole residue. From these, compound 8 showed activity similar to thiazomycin. Two compounds (9 and 10) showed intermediate activities, and the three truncated compounds (11-13) were essentially inactive. The discovery of the truncated compounds revealed the minimal structural requirements for activity and suggested probable biosynthetic pathways for more advanced compounds. The isolation, structure elucidation, antibacterial activity, and proposed biogenesis of thiazomycins are herein described.


Assuntos
Actinomycetales/química , Antibacterianos , Peptídeos Cíclicos/isolamento & purificação , Peptídeos , Tiazóis/isolamento & purificação , Antibacterianos/química , Antibacterianos/isolamento & purificação , Antibacterianos/farmacologia , Técnicas de Química Combinatória , Testes de Sensibilidade Microbiana , Estrutura Molecular , Peptídeos/química , Peptídeos/isolamento & purificação , Peptídeos/farmacologia , Peptídeos Cíclicos/química , Peptídeos Cíclicos/farmacologia , Estereoisomerismo , Tiazóis/química , Tiazóis/farmacologia
5.
J Am Chem Soc ; 130(36): 12102-10, 2008 Sep 10.
Artigo em Inglês | MEDLINE | ID: mdl-18698773

RESUMO

Bacterial resistance to antibiotics, particularly to multiple drug resistant antibiotics, is becoming cause for significant concern. The only really viable course of action is to discover new antibiotics with novel mode of actions. Thiazolyl peptides are a class of natural products that are architecturally complex potent antibiotics but generally suffer from poor solubility and pharmaceutical properties. To discover new thiazolyl peptides potentially with better desired properties, we designed a highly specific assay with a pair of thiazomycin sensitive and resistant strains of Staphylococcus aureus, which led to the discovery of philipimycin, a new thiazolyl peptide glycoside. It was isolated along with an acid-catalyzed degradation product by bioassay-guided fractionation. Structure of both compounds was elucidated by extensive application of 2D NMR, 1D TOCSY, and HRESIFT-MS/MS. Both compounds showed strong antibacterial activities against gram-positive bacteria including MRSA and exhibited MIC values ranging from 0.015 to 1 microg/mL. Philipimycin was significantly more potent than the degradation product. Both compounds showed selective inhibition of protein synthesis, indicating that they targeted the ribosome. Philipimycin was effective in vivo in a mouse model of S. aureus infection exhibiting an ED50 value of 8.4 mg/kg. The docking studies of philipimycin suggested that a part of the molecule interacts with the ribosome and another part with Pro23, Pro22, and Pro26 of L11 protein, which helped in explaining the differential of activities between the sensitive and resistant strains. The design and execution of the bioassay, the isolation, structure, in vitro and in vivo antibacterial activity, and docking studies of philipimycin and its degradation product are described.


Assuntos
Antibacterianos/química , Proteínas de Bactérias/química , Micromonosporaceae/química , Tiazóis/química , Antibacterianos/isolamento & purificação , Antibacterianos/farmacologia , Proteínas de Bactérias/isolamento & purificação , Proteínas de Bactérias/farmacologia , Glicosídeos/química , Glicosídeos/isolamento & purificação , Glicosídeos/farmacologia , Testes de Sensibilidade Microbiana , Modelos Moleculares , Peptídeos Cíclicos/farmacologia , Espectrometria de Massas por Ionização por Electrospray , Staphylococcus aureus/efeitos dos fármacos , Tiazóis/isolamento & purificação , Tiazóis/farmacologia
6.
Prog Drug Res ; 65: 291, 293-328, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-18084919

RESUMO

Today we use many drugs produced by microorganisms. However, when these drugs were discovered it was found that the yields were low and a substantial effort had to be put in to develop commercially viable processes. A key part of this endeavor was the studies of the nutritional and the engineering parameters. In this chapter, the basic principles of optimizing the nutritional and engineering aspect of the production process are described with appropriate examples. It was found that two critical components of nutritional medium, carbon and nitrogen source regulated the synthesis of the compounds of interest. Rapidly utilizable carbon source such as glucose supported the growth but led to catabolite repression and alternative carbon sources or methods of addition had to be devised. Inorganic nitrogen sources led to undesirable changes in pH of the medium. Organic nitrogen sources could influence the yields positively or negatively and had to be chosen carefully. Essential nutrients like phosphates often inhibited the synthesis and its concentration had to be maintained below the inhibitory levels. On many occasions, trace nutrients like metal ions and vitamins were found to be critical for good production. Temperature and pH were important environmental variables and their optimum values had to be determined. The media were designed and optimized initially with 'one variable at a time' approach and later with experimental design based on statistics. The latter approach is preferred because it is economical, considers interactions between medium components and allows rapid optimization of the process. The engineering aspects like aeration, agitation, medium sterilization, heat transfer, process monitoring and control, become critical as the process is scaled-up to the production size. Aeration and agitation are probably the most important variables. In many processes dissolved oxygen concentration had to be maintained above a critical value to obtain the best yields. The rheological properties of fermentation broth significantly affect the aeration and mixing efficiency. The removal of heat from the large fermentors can be difficult under certain conditions. However, new designs of impellers, availability of sensors to monitor important physiological and process variables and advent of computers have facilitated successful scale-up of fermentation processes.


Assuntos
Bactérias/metabolismo , Técnicas Bacteriológicas , Fatores Biológicos/metabolismo , Fermentação , Microbiologia Industrial , Fenômenos Fisiológicos da Nutrição , Preparações Farmacêuticas/metabolismo , Bactérias/crescimento & desenvolvimento , Carbono/metabolismo , Meios de Cultura/química , Concentração de Íons de Hidrogênio , Modelos Estatísticos , Nitrogênio/metabolismo , Projetos de Pesquisa , Reologia , Esterilização , Temperatura , Oligoelementos/metabolismo
7.
Bioorg Med Chem ; 16(19): 8818-23, 2008 Oct 01.
Artigo em Inglês | MEDLINE | ID: mdl-18804380

RESUMO

Thiazolyl peptides are a class of thiazole-rich macrocyclic potent antibacterial agents. Recently, we described thiazomycin, a new member of thiazolyl peptides, discovered by a thiazolyl peptide specific chemical screening. This method also allowed for the discovery of a new thiazolyl peptide, thiazomycin A, which carries modification in the oxazolidine ring of the amino sugar moiety. Thiazomycin A is a specific inhibitor of protein synthesis (IC(50) 0.7 microg/mL) and a potent Gram-positive antibacterial agent with minimum inhibitory concentration (MIC) ranging 0.002-0.25 microg/mL. The isolation and structure elucidation and biological activities of thiazomycin A are described.


Assuntos
Actinomycetales/química , Antibacterianos/farmacologia , Peptídeos Cíclicos/farmacologia , Staphylococcus aureus/efeitos dos fármacos , Tiazóis/farmacologia , Antibacterianos/química , Antibacterianos/isolamento & purificação , Concentração Inibidora 50 , Testes de Sensibilidade Microbiana , Oxazóis/química , Oxazóis/farmacologia , Peptídeos Cíclicos/química , Peptídeos Cíclicos/isolamento & purificação , Staphylococcus aureus/crescimento & desenvolvimento , Tiazóis/química , Tiazóis/isolamento & purificação
8.
J Antibiot (Tokyo) ; 60(9): 565-71, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17917239

RESUMO

Thiazomycin is a novel thiazolyl peptide closely related to nocathiacin I. It was isolated from Amycolatopsis fastidiosa by chemical and biological screening. Thiazomycin showed highly potent bactericidal activity against Gram-positive pathogens (MIC range 0.002 approximately 0.064 microg/ml) and did not show cross-resistance to clinically relevant antibiotic classes such as beta-lactams, vancomycin, oxazolidinone and quinolones. It was highly efficacious against Staphylococcus aureus infection in mice exhibiting an ED(99) value of 0.15 mg/kg by subcutaneous administration. It inhibited bacterial growth by selective inhibition of protein synthesis and it was thought to interact with L11 protein and 23S rRNA of the 50S ribosome. Structurally, it possesses an oxazolidine ring in the amino-sugar residue that provides further opportunities for selective chemical modifications that are not feasible with other thiazolyl peptides. More importantly such a modification can potentially lead to semi-synthetic compounds that overcome problems that have hampered clinical development of this class of compounds. Despite its positive attributes, emergence of an unacceptable frequency of resistance poses significant challenges for further development of thiazomycin and this class of molecules for therapeutic use.


Assuntos
Actinomycetales/química , Antibacterianos/farmacologia , Peptídeos Cíclicos/farmacologia , Inibidores da Síntese de Proteínas/farmacologia , Infecções Estafilocócicas/tratamento farmacológico , Tiazóis/farmacologia , Animais , Antibacterianos/isolamento & purificação , Farmacorresistência Bacteriana , Camundongos , Testes de Sensibilidade Microbiana , Mutação , Peptídeos/isolamento & purificação , Peptídeos/farmacologia , Peptídeos Cíclicos/isolamento & purificação , Inibidores da Síntese de Proteínas/isolamento & purificação , RNA Ribossômico/efeitos dos fármacos , Staphylococcus aureus/efeitos dos fármacos , Tiazóis/isolamento & purificação
9.
J Antibiot (Tokyo) ; 60(9): 554-64, 2007 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-17917238

RESUMO

Thiazolyl peptides are a class of rigid macrocyclic compounds richly populated with thiazole rings. They are highly potent antibiotics but none have been advanced to clinic due to poor aqueous solubility. Recent progress in this field prompted a reinvestigation leading to the isolation of a new thiazolyl peptide, thiazomycin, a congener of nocathiacins. Thiazomycin possesses an oxazolidine ring as part of the amino-sugar moiety in contrast to the dimethyl amino group present in nocathiacin I. The presence of the oxazolidine ring provides additional opportunities for chemical modifications that are not possible with other nocathiacins. Thiazomycin is extremely potent against Gram-positive bacteria both in vitro and in vivo. The titer of thiazomycin in the fermentation broth was very low compared to the nocathiacins I and III. The lower titer together with its sandwiched order of elution presented significant challenges in large scale purification of thiazomycin. This problem was resolved by the development of an innovative preferential protonation based one- and/or two-step chromatographic method, which was used for pilot plant scale purifications of thiazomycin. The isolation and structure elucidation of thiazomycin is herein described.


Assuntos
Actinomycetales/química , Antibacterianos/isolamento & purificação , Peptídeos Cíclicos/isolamento & purificação , Tiazóis/isolamento & purificação , Actinomycetales/classificação , Antibacterianos/química , Cromatografia Líquida/métodos , Fermentação , Bactérias Gram-Positivas/efeitos dos fármacos , Peptídeos e Proteínas de Sinalização Intercelular , Mutação , Peptídeos/química , Peptídeos/isolamento & purificação , Peptídeos Cíclicos/química , Solubilidade , Tiazóis/química
10.
J Biomol Screen ; 11(6): 704-11, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16844965

RESUMO

Several protocols for bacterial isolation and techniques for aerobic plate counting rely on the use of a spiral plater to deposit concentration gradients of microbial suspensions onto a circular agar plate to isolate colony growth. The advantage of applying a gradient of concentrations across the agar surface is that the original microbiological sample can be applied at a single concentration rather than as multiple serial dilutions. The spiral plater gradually dilutes the sample across a compact area and therefore saves time preparing dilutions and multiple agar plates. Commercial spiral platers are not automated and require manual sample loading. Dispensing of the sample volume and rate of gradients are often very limited in range. Furthermore, the spiral sample application cannot be used with rectangular microplates. Another limitation of commercial spiral platers is that they are useful only for dilute, filtered suspensions and cannot plate suspensions of coarse organic particles therefore precluding the use of many kinds of microorganism-containing substrata. An automated agar plate spreader capable of processing 99 rectangular microplates in unattended mode is described. This novel instrument is capable of dispensing discrete volumes of sample in a linear pattern. It can be programmed to dispense a sample suspense at a uniform application rate or across a decreasing concentration gradient.


Assuntos
Técnicas Microbiológicas/instrumentação , Manejo de Espécimes/instrumentação , Ágar , Automação , Meios de Cultura , Padrões de Referência
11.
Neurotox Res ; 25(2): 183-91, 2014 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-23959949

RESUMO

Previously, we have pioneered Drosophila melanogaster as a reductionist model to show that 1-octen-3-ol, a musty-smelling volatile compound emitted by fungi and other organisms, causes loss of dopaminergic neurons and Parkinson's disease-like symptoms in flies. Using our in vivo Drosophila system, the modulatory roles of important signaling pathways­JNK, Akt and the caspase-3-dependent apoptotic pathway were investigated in the context of 1-octen-3-ol-induced dopamine neurotoxicity. When heterozygous flies carrying mutant alleles for these proteins were exposed to 0.5 ppm of 1-octen-3-ol, they had shorter survival times than wild-type Drosophila. The overexpressed levels of wild-type JNK and Akt, (UAS-bsk and UAS-Akt) with TH-GAL4 and elav-GAL4 drivers improved the survival duration of exposed flies compared with controls. Thus, we found that Akt and JNK both protect against loss of dopamine activity associated with 1-octen-3-ol exposure, indicating the pro-survival role of these signaling pathways. Further, 1-octen-3-ol exposure was associated with activation of caspase 3, a hallmark for apoptosis.


Assuntos
Caspase 3/metabolismo , Neurônios Dopaminérgicos/metabolismo , Sistema de Sinalização das MAP Quinases/fisiologia , Octanóis/toxicidade , Doença de Parkinson/metabolismo , Proteínas Proto-Oncogênicas c-akt/metabolismo , Animais , Caspase 3/efeitos dos fármacos , Modelos Animais de Doenças , Neurônios Dopaminérgicos/efeitos dos fármacos , Drosophila melanogaster , Sistema de Sinalização das MAP Quinases/efeitos dos fármacos , Doença de Parkinson/enzimologia , Proteínas Proto-Oncogênicas c-akt/efeitos dos fármacos
12.
J Antibiot (Tokyo) ; 66(10): 599-607, 2013 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-23801187

RESUMO

Natural products have been major sources of antibacterial agents and remain very promising. Frequent rediscoveries of known compounds hampers progress of new discoveries and demands development and utilization of new methods for rapid biological and chemical dereplication. This paper describes an efficient approach for discovery of new thiazolyl peptides by sensitive-resistant pair screening and dereplication in a time and cost-effective manner at industrial scale. A highly effective library-based dereplication of thiazolyl peptides by high resolution fourier transform liquid chromatography mass spectrometry (HRFTLCMS) has been developed, which can detect and dereplicate very low levels of thiazolyl peptides particularly when combined with miniaturized high-throughput 96-well solid-phase extraction separation, and as well can be automated. Combination of sensitive (susceptible)-resistant pair screening, diversified screening collection and miniaturized high-throughput SPE and HRFTLCMS techniques were applied for discovery of new thiazolyl peptides. The combined approach allowed for identification of over 24 thiazolyl peptides represented by three of the five structural subgroups, including three novel compounds. In addition, it is possible for the first time to mechanistically group three structural subgroups of over 24 thiazolyl peptides. Furthermore, these studies helped to understand natural frequency of distribution of these compounds and helped in discovery of new producing strains of many thiazolyl compounds.


Assuntos
Actinobacteria/metabolismo , Antibacterianos/farmacologia , Produtos Biológicos/farmacologia , Peptídeos Cíclicos/farmacologia , Peptídeos/farmacologia , Tiazóis/farmacologia , Antibacterianos/química , Antibacterianos/metabolismo , Produtos Biológicos/química , Produtos Biológicos/metabolismo , Cromatografia Líquida , Farmacorresistência Bacteriana , Análise de Fourier , Ensaios de Triagem em Larga Escala/métodos , Espectrometria de Massas/métodos , Testes de Sensibilidade Microbiana/métodos , Peptídeos/química , Peptídeos/metabolismo , Tiazóis/química , Tiazóis/metabolismo
13.
Toxicol Sci ; 117(2): 418-26, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20643751

RESUMO

Many volatile organic compounds (VOCs) are found in indoor environment as products of microbial metabolism. In damp indoor environments, fungi are associated with poor air quality. Some epidemiological studies have suggested that microbial VOCs have a negative impact on human health. Our study was designed to provide a reductionist approach toward studying fungal VOC-mediated toxicity using the inexpensive model organism, Drosophila melanogaster, and pure chemical standards of several important fungal VOCs. Low concentrations of the following known fungal VOCs, 0.1% of 1-octen-3-ol and 0.5% of 2-octanone; 2,5 dimethylfuran; 3-octanol; and trans-2-octenal, caused locomotory defects and changes in green fluorescent protein (GFP)- and antigen-labeled dopaminergic neurons in adult D. melanogaster. Locomotory defects could be partially rescued with L-DOPA. Ingestion of the antioxidant, vitamin E, improved the survival span and delayed the VOC-mediated changes in dopaminergic neurons, indicating that the VOC-mediated toxicity was due, in part, to generation of reactive oxygen species.


Assuntos
Drosophila melanogaster/fisiologia , Fungos/metabolismo , Sistema Nervoso/efeitos dos fármacos , Neurotoxinas/toxicidade , Compostos Orgânicos Voláteis/toxicidade , Poluição do Ar/análise , Animais , Dopamina/metabolismo , Monitoramento Ambiental/métodos , Fungos/química , Proteínas de Fluorescência Verde/metabolismo , Habitação , Levodopa/farmacologia , Locomoção/efeitos dos fármacos , Masculino , Modelos Animais , Sistema Nervoso/metabolismo , Sistema Nervoso/fisiopatologia , Neurônios/efeitos dos fármacos , Neurônios/metabolismo , Extratos Vegetais/toxicidade , Vitamina E/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA